1 Function (all scores/instruments): short term (up to 3 months follow‐up) |
4 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.1 Tendinopathies |
3 |
122 |
Std. Mean Difference (IV, Random, 95% CI) |
0.14 [‐0.38, 0.67] |
1.2 Augmentation procedures |
1 |
40 |
Std. Mean Difference (IV, Random, 95% CI) |
0.62 [‐0.02, 1.25] |
2 Function (all scores/instruments): medium term (over 3 months, under 1 year follow‐up) |
5 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.1 Tendinopathies |
3 |
98 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.02 [‐0.83, 0.78] |
2.2 Augmentation procedures |
2 |
53 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.22 [‐0.77, 0.32] |
3 Functional (all scores/instruments): long term (1 year or more follow‐up) |
10 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
3.1 Tendinopathies |
1 |
54 |
Std. Mean Difference (IV, Random, 95% CI) |
0.03 [‐0.51, 0.56] |
3.2 Augmentation procedures |
9 |
430 |
Std. Mean Difference (IV, Random, 95% CI) |
0.28 [‐0.08, 0.64] |
4 Pain (VAS: 0 to 10: worst pain): short term (up to 3 months follow‐up) |
4 |
175 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.95 [‐1.41, ‐0.48] |
4.1 Tendinopathies |
1 |
28 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.86 [‐1.51, ‐0.21] |
4.2 Augmentation procedures |
3 |
147 |
Mean Difference (IV, Fixed, 95% CI) |
‐1.04 [‐1.71, ‐0.37] |
5 Pain (VAS: 0 to 10: worst pain): medium term (over 3 months, under 1 year follow‐up |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
5.1 Tendinopathies |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5.2 Augmentation procedures |
0 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6 Pain (VAS: 0 to 10: worst pain): long term (1 year or more follow‐up) |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
6.1 Tendinopathies |
0 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.2 Augmentation procedures |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
7 Adverse effects (any of PRT pr placebo application |
11 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
7.1 Tendinopathies |
2 |
94 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.33 [0.34, 5.21] |
7.2 Augmentation procedures |
9 |
392 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.29 [0.29, 5.71] |